Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
09/2013
09/24/2013US8541410 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
09/24/2013US8541404 Inhibitors of the human aldosterone synthase CYP11B2
09/24/2013US8541403 Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency
09/24/2013US8541402 Viral polymerase inhibitors
09/24/2013US8540521 Benzoxazole-based fluorescent metal ion indicators
09/24/2013CA2728350C Fxa inhibitors with cyclic amidoxime or cyclic amidrazone as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof
09/24/2013CA2545425C Azole-based kinase inhibitors
09/24/2013CA2474277C 2,4-pyrimidinediamine compounds and their uses
09/19/2013WO2013136288A1 Substituted 3,4-dihydro-2h-benzo[b] [1,4]oxazine compounds as calcium sensing receptor modulators
09/19/2013WO2013135674A1 Insecticidal 2-aryl-acetamide compounds
09/19/2013US20130245256 Quinazoline analogs as receptor tyrosine kinase inhibitors
09/19/2013US20130245072 Insecticidal compounds
09/19/2013US20130245034 Inhibitors Of Histone Deacetylase
09/19/2013US20130245025 Compounds that modulate intracellular calcium
09/19/2013US20130245022 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
09/19/2013US20130245017 Crystalline form of rivaroxaban dihydrate
09/19/2013US20130245005 Quinolin-4 (1h) -one derivatives as inhibitors of phosphatidylinositol 3-kinases
09/19/2013US20130244993 Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
09/18/2013EP2639226A1 Anti-infective pyrimidines and uses thereof
09/18/2013EP2638035A1 Triazole derivatives as ligands for gaba receptors
09/18/2013EP2638034A1 Substituted heteroaromatic carboxamide and urea derivatives as vanilloid receptor ligands
09/18/2013EP2638031A1 Pyrazole aminopyrimidine derivatives as lrrk2 modulators
09/18/2013EP2638029A1 Triazole derivatives and their use for neurological disorders
09/18/2013EP2638026A2 Chromene derivatives and their analoga as wnt pathway antagonists
09/18/2013EP2638025A2 Chromene derivatives and their analoga as wnt pathway antagonists
09/18/2013EP2638022A1 Oxazolidinones as modulators of mglur5
09/18/2013EP2638021A2 Metalloenzyme inhibitor compounds
09/18/2013EP2638018A1 Pyridine compounds and aza analogues thereof as tyk2 inhibitors
09/18/2013EP2638012A1 Pyridyl ureas as mineralocorticoid receptor antagonists
09/18/2013EP2638009A2 Fluorinated hdac inhibitors and uses thereof
09/18/2013EP2637659A1 Sgc stimulators
09/18/2013CN1578779B Small organic molecule regulators of cell proliferation
09/18/2013CN103313984A Methyltetrazole sulfides and sulfones
09/18/2013CN103313983A Process for the preparation of statins in the presence of base
09/18/2013CN103313982A Phenyl-isoxazol derivatives and preparation process thereof
09/18/2013CN103313981A 2-methoxy-pyridin-4-yl derivatives
09/18/2013CN103313978A Pyrazole aminopyrimidine derivatives as LRRK2 modulators
09/18/2013CN103313977A 1-(heterocyclic carbonyl) piperidines
09/18/2013CN103313976A SGC stimulators
09/18/2013CN103313970A Novel bicyclic compound or salt thereof
09/18/2013CN103313968A Nampt and rock inhibitors
09/18/2013CN103304558A Spirofluorene xanthene benzoxazine containing benzoyloxy group and preparation method thereof
09/18/2013CN103304557A Organic semiconductor material containing spirofluorene, preparation method thereof and organic light-emitting device
09/18/2013CN103304556A Schiff base compound containing benzopyran, preparation method and use thereof
09/18/2013CN103304555A Group of benzene-oxazolyl derivatives and preparation method as well as relevant application thereof as IMPDH (Inosine Monophosphate Dehydrogenase) inhibitor
09/18/2013CN103304541A Viral polymerase inhibitors
09/18/2013CN103304507A Green method for preparing heterocyclic compounds from nitriles
09/18/2013CN102174042B 免疫抑制剂化合物和组合物 Immunosuppressive compounds and compositions
09/18/2013CN102006873B Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor
09/18/2013CN101910150B 4-benzylamino-1-carboxyacyl-piperidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
09/18/2013CN101878199B 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis
09/18/2013CN101535305B 5-hydroxymethyl-oxazolidin-2-one derivatives
09/18/2013CN101495472B Fungicide N-cycloalkyl-carboxamide derivatives
09/18/2013CN101384581B Benzoyl-piperidine derivatives as 5HT2/D3 modulators
09/17/2013US8536340 Cross-linked cyclic amine compounds and agents for pest control
09/17/2013US8536203 Pharmaceutical compounds
09/17/2013US8536198 Piperidine derivatives as modulators of chemokine receptor activity
09/17/2013US8536182 Benzylpiperazine derivatives and their medical use
09/17/2013US8536180 Pyrimidine inhibitors of kinase activity
09/17/2013US8536177 Therapeutic agents useful for treating pain
09/17/2013US8536169 Compounds
09/17/2013US8536166 Inhibitors of Burton's tyrosine kinase
09/17/2013US8536092 Anthranilic acid diamide derivative with hetero-aromatic and hetero-cyclic substituents
09/17/2013CA2694136C Pi3 kinase modulators and methods of use
09/17/2013CA2649043C Azolecarboxamide derivative
09/12/2013WO2013134415A1 Mannose derivatives for treating bacterial infections
09/12/2013WO2013134079A1 Oxazolidinone compounds and derivatives thereof
09/12/2013WO2013134061A1 Phenicol antibacterials
09/12/2013WO2013132509A1 Novel compounds for the treatment of dyslipidemia and related diseases
09/12/2013WO2013132270A1 Phosphoinositide 3-kinase inhibitors
09/12/2013WO2013131935A1 Pyridinone and pyridazinone derivatives as mch - receptor modulators
09/12/2013WO2013043232A8 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of nervous system disorders and cancer
09/12/2013US20130237702 Alkylamine derivative
09/12/2013US20130237572 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
09/12/2013US20130237566 Heterocyclic compounds as s1p1 agonists for the treatment of autoimmune and vascular diseases
09/12/2013US20130237552 Sulfur derivatives as chemokine receptor modulators
09/12/2013US20130237548 Injectable emulsion of sedative hypnotic agent
09/12/2013US20130237545 Pyridazine derivatives, compositions and methods for treating cognitive impairment
09/12/2013US20130237525 Lactam derivatives useful as orexin receptor antagonists
09/12/2013US20130237522 Carboxylic acid amides, the preparation thereof and their use as medicaments
09/12/2013US20130237518 Novel compounds that are erk inhibitors
09/12/2013US20130237515 New compounds, pharmaceutical compositions and uses thereof
09/12/2013US20130237514 Pyrrolidinone carboxamide derivatives
09/11/2013EP2636669A1 Pyrazole amide compound and use thereof
09/11/2013EP2636414A1 Preventive or therapeutic agent for pain associated with herpes zoster in acute phase
09/11/2013EP2635573A1 Heterocyclic compounds as s1p1 agonists for the treatment of autoimmune and vascular diseases
09/11/2013EP2635572A2 Compounds useful as modulators of trpm8
09/11/2013EP2635567A1 Indole derivatives
09/11/2013EP2635564A1 N-hetarylmethyl pyrazolylcarboxamides
09/11/2013EP2635562A1 Pyrrolidine derivatives used as cathepsin inhibitors
09/11/2013EP2635560A1 Dihydrooxazol-2-amine derivatives
09/11/2013EP2635559A2 Neurotrypsin inhibitors
09/11/2013EP2635275A1 Gpr17-modulating compounds, diagnostic and therapeutic uses thereof
09/11/2013CN103298808A Novel ureas for the treatment and prevention of cancer
09/11/2013CN103298807A Heterocyclic compounds as S1P1 agonists for the treatment of autoimmune and vascular diseases
09/11/2013CN103298806A Substituted pyridazine carboxamide compounds
09/11/2013CN103298805A Quinazoline compounds and methods of use thereof
09/11/2013CN103298802A N-hetarylmethyl pyrazolylcarboxamides
09/11/2013CN103298800A Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/11/2013CN103298799A Heterocyclic compounds suitable for the treatment of dyslipidemia
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 647